For example, if a generic Part D rebatable drug or biosimilar that is currently in shortage in the applicable period beginning October 1, 2024 is granted a severe supply chain disruption rebate reduction request as a result of a natural disaster that occurs on April 5, 2025, CMS would apply a 75 percent reduction in the rebate amount for the duration of the applicable period in which the natural disaster occurred (that is, October 1, 2024, to September 30, 2025)
Picture this: four sprays from a weakly atomized travel decant, a modest gesture, I thought, to christen my day
These pouches dont cause premature color changes
#5 Wow, those pipes really pop
According to figures from the Public Health Agency of Sweden, 19 per cent of men and 4 per cent of women in Sweden take snus